kynurenine has been researched along with Diabetic Glomerulosclerosis in 3 studies
Kynurenine: A metabolite of the essential amino acid tryptophan metabolized via the tryptophan-kynurenine pathway.
kynurenine : A ketone that is alanine in which one of the methyl hydrogens is substituted by a 2-aminobenzoyl group.
| Excerpt | Relevance | Reference |
|---|---|---|
| "We recruited 40 type II diabetes mellitus (T2DM) patients with or without DKD from a single center for a cross-sectional study." | 1.91 | Serum metabolomics detected by LDI-TOF-MS can be used to distinguish between diabetic patients with and without diabetic kidney disease. ( Jin, J; Qian, F; Yu, M; Zhang, D; Zhao, L; Zhou, W, 2023) |
| "Kynurenine levels were significantly lower in the group under RASis compared to the untreated group (1." | 1.56 | RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus. ( Benvenga, S; Bolignano, D; Buemi, M; Cernaro, V; Cigala, RM; Crea, F; De Stefano, C; Ferlazzo, VT; Gembillo, G; Genovese, ARR; Loddo, S; Macaione, V; Santoro, D; Vita, R, 2020) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 2 (66.67) | 2.80 |
| Authors | Studies |
|---|---|
| Qian, F | 1 |
| Zhao, L | 1 |
| Zhang, D | 1 |
| Yu, M | 1 |
| Zhou, W | 1 |
| Jin, J | 1 |
| Cernaro, V | 1 |
| Loddo, S | 1 |
| Macaione, V | 1 |
| Ferlazzo, VT | 1 |
| Cigala, RM | 1 |
| Crea, F | 1 |
| De Stefano, C | 1 |
| Genovese, ARR | 1 |
| Gembillo, G | 1 |
| Bolignano, D | 1 |
| Santoro, D | 1 |
| Vita, R | 1 |
| Buemi, M | 1 |
| Benvenga, S | 1 |
| Perkins, BA | 1 |
| Rabbani, N | 1 |
| Weston, A | 1 |
| Ficociello, LH | 1 |
| Adaikalakoteswari, A | 1 |
| Niewczas, M | 1 |
| Warram, J | 1 |
| Krolewski, AS | 1 |
| Thornalley, P | 1 |
3 other studies available for kynurenine and Diabetic Glomerulosclerosis
| Article | Year |
|---|---|
Serum metabolomics detected by LDI-TOF-MS can be used to distinguish between diabetic patients with and without diabetic kidney disease.
Topics: Creatinine; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Nephropathies; Humans; Kynu | 2023 |
RAS inhibition modulates kynurenine levels in a CKD population with and without type 2 diabetes mellitus.
Topics: Aged; Aged, 80 and over; Angiotensins; Correlation of Data; Cross-Sectional Studies; Diabetes Mellit | 2020 |
Serum levels of advanced glycation endproducts and other markers of protein damage in early diabetic nephropathy in type 1 diabetes.
Topics: Adult; Albuminuria; Arginine; Biomarkers; Blood Proteins; Chromatography, Liquid; Cystatin C; Diabet | 2012 |